Is there a role for advanced radiation therapy technologies in the treatment of pancreatic adenocarcinoma?
Pancreatic cancer remains a highly challenging problem in oncology. Oncologists continue to search for therapies that are more effective than those currently available to improve on the existing poor treatment results. Persistence of both systemic and local disease causes high rates of morbidity and mortality for patients. Radiation continues to play a role in the treatment of pancreatic cancer, in both the adjuvant and locally advanced settings. Efforts to improve on the results of radiotherapy have led to the use of new and improved technologies. This review discusses a variety of these technological improvements and their current and potential future roles in the clinic.
Meyer
Jeffrey John
JJ
Duke University Medical Center, Department of Radiation Oncology, DUMC Box 3085, Durham, NC 27710, USA. jeffrey.meyer@duke.edu
Willett
Christopher George
CG
Czito
Brian Gary
BG
D000230:Adenocarcinoma / Q000532:radiotherapy*; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D010190:Pancreatic Neoplasms / Q000532:radiotherapy*; D016499:Radioimmunotherapy; D011878:Radiotherapy / Q000379:methods*